Cytarabine.

Area of Science:

• Oncology
• Hematology
• Neuro-oncology

Background:

• Cytarabine is a chemotherapy agent used in cancer treatment.
• It has demonstrated efficacy in treating leukemias and central nervous system (CNS) disease.

Purpose of the Study:

• To summarize the established efficacy of cytarabine.
• To highlight ongoing research into high-dose cytarabine therapy.

Main Methods:

• Review of existing clinical data on cytarabine administration.
• Identification of current research trends in high-dose cytarabine therapy.

Main Results:

• Cytarabine is effective via subcutaneous (SQ), intramuscular (IM), intravenous (IV), and intrathecal administration.
• Research is actively investigating the outcomes and safety of high-dose cytarabine regimens.

Conclusions:

• Cytarabine remains a valuable therapeutic option for leukemias and CNS disease.
• Further investigation into high-dose cytarabine is warranted to optimize treatment strategies.